TherapeuticsMD (TXMD) Capital Expenditures (QoQ) (2011 - 2022)
TherapeuticsMD (TXMD) Capital Expenditures (QoQ) (2011 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | TherapeuticsMD | 21,180.42 | -8.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -150.00% |
| Sep 30, 2021 | -270.73% |
| Jun 30, 2021 | -34.92% |
| Mar 31, 2021 | -62.50% |
| Dec 31, 2020 | 1,192.31% |
| Sep 30, 2020 | 160.00% |
| Jun 30, 2020 | -76.19% |
| Mar 31, 2020 | -94.18% |
| Dec 31, 2019 | -63.83% |
| Sep 30, 2019 | 20.10% |
| Jun 30, 2019 | 216.32% |
| Mar 31, 2019 | 74.08% |
| Dec 31, 2018 | 632.66% |
| Sep 30, 2018 | 9.37% |
| Jun 30, 2018 | -30.09% |
| Mar 31, 2018 | 3.62% |
| Jun 30, 2017 | -71.20% |
| Mar 31, 2017 | -68.53% |
| Dec 31, 2016 | 107.23% |
| Sep 30, 2016 | -77.60% |